160 related articles for article (PubMed ID: 324678)
1. C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay.
Tappeiner G; Heine KG; Kahl JC; Jordon RE
Clin Exp Immunol; 1977 Apr; 28(1):40-8. PubMed ID: 324678
[TBL] [Abstract][Full Text] [Related]
2. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
Jordon RE; Nordby JM; Milstein H
J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study on 70 human embryos concerning the epidermal binding of pemphigus and pemphigoid antibodies.
Varelzidis A; Tosca A; Coumantakis E; Nicolis G; Hatzis J; Papavasiliou S; Stratigos J
Acta Derm Venereol; 1980; 60(2):129-33. PubMed ID: 6155018
[TBL] [Abstract][Full Text] [Related]
4. Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor.
Jordon RE; Struve MF; Bushkell LL
Clin Exp Immunol; 1981 Jul; 45(1):29-36. PubMed ID: 7030538
[TBL] [Abstract][Full Text] [Related]
5. [Bullous pemphigoid with pemphigus type antibodies in vivo. 2 cases].
Bernard P; Catanzano G; Vignaud St Florent JD; Fayol J; Bonnetblanc JM
Ann Dermatol Venereol; 1986; 113(8):671-6. PubMed ID: 3541760
[TBL] [Abstract][Full Text] [Related]
6. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.
Zubler RH; Lange G; Lambert PH; Miescher PA
J Immunol; 1976 Jan; 116(1):232-5. PubMed ID: 1245740
[TBL] [Abstract][Full Text] [Related]
7. Immune complexes in pemphigus and bullous pemphigoid.
Ahmed AR; Moy RL; Chia D; Barnett EV
Dermatologica; 1983; 166(4):175-80. PubMed ID: 6343146
[TBL] [Abstract][Full Text] [Related]
8. Serum and blister fluid anticomplementary activity in pemphigus and bullous pemphigoid. Sucrose density gradient studies.
Jordon RE; McDuffie FC
Proc Soc Exp Biol Med; 1976 Mar; 151(3):594-8. PubMed ID: 768993
[TBL] [Abstract][Full Text] [Related]
9. Detection of immune complex-like materials in cancer patients' sera: a comparative study of results obtained with the C1q deviation and C1q binding tests.
Rossen RD; Zubler RH; Day NK; Reisberg MA; Morgan AC; Gutterman JU; Hersh EM
J Lab Clin Med; 1978 Feb; 91(2):191-204. PubMed ID: 413872
[TBL] [Abstract][Full Text] [Related]
10. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
[TBL] [Abstract][Full Text] [Related]
11. Complement activation in pemphigus and bullous pemphigoid.
Jordon RE
J Invest Dermatol; 1976 Sep; 67(3):366-71. PubMed ID: 787432
[No Abstract] [Full Text] [Related]
12. Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.
Anhalt GJ; Patel H; Diaz LA
Arch Dermatol; 1983 Sep; 119(9):711-4. PubMed ID: 6351756
[No Abstract] [Full Text] [Related]
13. Circulating and tissue-bound immune complexes in allergic vasculitis: relationship between immunoglobulin class and clinical features.
Kauffmann RH; Herrmann WA; Meijer CJ; Daha MR; Vanes LA
Clin Exp Immunol; 1980 Sep; 41(3):459-70. PubMed ID: 7438561
[TBL] [Abstract][Full Text] [Related]
14. A comparison of two 125I C1q binding tests to detect soluble immune complexes in serum of patients with malignant disease.
Shepherd PS
Clin Exp Immunol; 1979 May; 36(2):250-5. PubMed ID: 477028
[TBL] [Abstract][Full Text] [Related]
15. Identification of different circulating autoantibodies in patients with bullous pemphigoid and pemphigus vulgaris by means of immunoblotting.
Kiss M; Husz S; Molnár K; Dobozy A
Acta Microbiol Immunol Hung; 1996; 43(2-3):115-23. PubMed ID: 8876727
[TBL] [Abstract][Full Text] [Related]
16. [Detection of circulating immune complexes by the C1q complement fraction deviation test. 1st application in the study of human glomerulopathies].
Sobel A; Gabay Y; Lagrue G
Nouv Presse Med; 1976 Jun; 5(23):1465-9. PubMed ID: 132639
[TBL] [Abstract][Full Text] [Related]
17. Binding of bullous pemphigoid antibodies to basal cells.
Nishikawa T; Kurihara S; Harada T; Hatano H
J Invest Dermatol; 1980 Jun; 74(6):389-91. PubMed ID: 6991608
[TBL] [Abstract][Full Text] [Related]
18. [Pemphigus and pemphigoid].
Stewart WM
Dermatologica; 1980; 160(4):217-35. PubMed ID: 6987108
[TBL] [Abstract][Full Text] [Related]
19. [Application of the biotin-avidin system to the study of autoimmune bullous diseases: immunofluorescence method using biotinylated-pemphigus and -pemphigoid antibodies and fluoresceinated avidin].
Muramatsu T; Sakamoto K; Ikeda S
Nihon Hifuka Gakkai Zasshi; 1988 Sep; 98(10):977-80. PubMed ID: 3065537
[No Abstract] [Full Text] [Related]
20. Binding of bullous pemphigoid and pemphigus vulgaris sera to SCaBER cell line in an ELISA.
Cook AL; Mallett RB; Hanahoe TH; Pye RJ
Br J Dermatol; 1989 Jan; 120(1):59-69. PubMed ID: 2700665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
